Price Chart

Profile

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It isĀ engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
URL https://www.pdsbiotech.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Nov. 14, 2024 (est.)
Last Earnings Release Aug. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It isĀ engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
URL https://www.pdsbiotech.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Nov. 14, 2024 (est.)
Last Earnings Release Aug. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A